On an average, rheumatoid arthritis is associated with one or more comorbid conditions and these comorbidities are associated with various risk factors and medications use in patients with RA. The aim of this study was to assess comorbidities in patients with RA at a tertiary care hospital of Northeast India. This cross sectional study was conducted for 8 months from August 2014 to April 2015. The data was collected from medicine (unit-III) outpatient department of Gauhati Medical College and Hospital, Guwahati, Northeast India. Fifty one RA patients were found during study period. Patientís socio-demographic characteristics, comorbidities, risk factors for comorbidities, laboratory investigations, and past & current medications use were collected during their visit to hospital. DAS28 scale was used to assess the disease activity in RA patients. Descriptive statistics were used. Non-normally distributed continuous variables are presented in median and interquartile range. The median age of RA patients was 45(IQR;15). The disease activity was found high (DAS-ESR>5.1) in 34 (66.67%) patients. The median DAS28 score was 5.64(IQR;1.44). Majority of the patients with RA were anaemic (n=34, 66.67%) followed by infection (n=7, 13.73%), thyroid disease (n=5, 9.80%), renal disease (n=4, 7.84%), osteoporosis (n=3, 5.88%), cardiovascular disease (n=3, 5.88%), lung disease (n=3, 5.88%), and vasculitis (n=1, 1.96%). The commonly reported risk factor was hypertension (19.61%) followed by diabetes (n=5, 9.80%), dyslipidemia (n=4, 7.84%), smoking (n=4, 7.84%), family history of CVD (n=2, 3.92%), and alcohol intake (n=1, 1.96%). Among DMARDS, methotrexate (92.16%) was the most commonly prescribed drug followed by hydroxychloroquine (74.51%) and sulfasalazine (27.45%). Anaemia was the most common comorbid condition found in RA patients. Disease activity was found high in anaemic patients with RA.
RA, Patients, DMARDS, Anemia, Comorbidities
Chemometric analysis of the global pattern of volatile organic compounds in the exhaled breath of patients with COVID-19, post-COVID and healthy subjects. Proof of concept for post-COVID assessment.
Zamora-Mendoza BN, D√≠az de Le√≥n-Mart√≠nez L, Rodr√≠guez-Aguilar M, Mizaikoff B, Flores-Ram√≠rez R
Talanta. 2022; 236(): 122832
Current Best Practices for Acute and Chronic Management of Patients with Opioid Use Disorder.
Peterkin A, Laks J, Weinstein ZM
The Medical clinics of North America. 2022; 106(1): 61-80
Long non-coding RNA profiles in plasma exosomes of patients with gastric high-grade intraepithelial neoplasia.
Hu F, Rao M, Zhang M, Meng Q, Wan M, Zhang X, Ding L, Jiang Y
Experimental and therapeutic medicine. 2022; 23(1): 1
Association of HLA-DRB1 and -DQB1 Alleles with Susceptibility to IgA Nephropathy in Korean Patients.
In JW, Jung K, Shin S, Park KU, Lee H, Song EY
Annals of laboratory medicine. 2022; 42(1): 54-62
Comprehensive Laboratory Data Analysis to Predict the Clinical Severity of Coronavirus Disease 2019 in 1,952 Patients in Daegu, Korea.
Yoo EH, Chang SH, Song DY, Lee CH, Cheong GY, Park S, Lee JH, Lee S, Kwak SG, Jeon CH, Song KE
Annals of laboratory medicine. 2022; 42(1): 24-35